Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century

被引:2
|
作者
Mheid, Sara [1 ]
Allen, Stefan [2 ]
Ng, Sylvia S. W. [3 ]
Hall, William A. [4 ]
Sanford, Nina N. [5 ]
Aguilera, Todd A. [5 ]
Elamir, Ahmed M. [5 ]
Bahij, Rana [6 ]
Intven, Martijn P. W. [7 ]
Radhakrishna, Ganesh [8 ]
Mohamad, Issa [9 ]
De Leon, Jeremy [10 ]
Tan, Hendrick [11 ,12 ]
Lewis, Shirley [13 ]
Gani, Cihan [14 ]
Stanecu, Teo [1 ]
Dell'Acqua, Veronica [15 ]
Hosni, Ali [1 ]
机构
[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
[2] Dalhousie Univ, Dept Radiat Oncol, Nova Scotia Hlth, Halifax, NS B3H 4R2, Canada
[3] Univ Toronto, Odette Canc Ctr, Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol, Toronto, ON M4N 3M5, Canada
[4] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA
[5] Univ Texas Southwestern, Dept Radiat Oncol, Dallas, TX 75235 USA
[6] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark
[7] Univ Med Ctr, Dept Radiotherapy, Div Imaging & Oncol, NL-3584 CX Utrecht, Netherlands
[8] Christie NHS Fdn Trust, Dept Radiotherapy, Manchester M20 4BX, England
[9] King Hussein Canc Ctr, Dept Radiat Oncol, Amman 11941, Jordan
[10] GenesisCare, Alexandria, NSW 2015, Australia
[11] Fiona Stanley Hosp, Dept Radiat Oncol, Perth, WA 6150, Australia
[12] GenesisCare, Perth, WA 6150, Australia
[13] Manipal Acad Higher Educ, Kasturba Med Coll, Manipal Comprehens Canc Care Ctr, Dept Radiotherapy & Oncol, Manipal 576104, India
[14] Univ Hosp Tubingen, Dept Radiat Oncol, D-72076 Tubingen, Germany
[15] Linac Based RT, Med Affairs & Clin Res, I-20864 Milan, Lombardy, Italy
关键词
liver; SBRT; oligometastases; DOSE-ESCALATION TRIAL; PHASE-I/II TRIAL; RADIOFREQUENCY ABLATION; COLORECTAL-CANCER; MOTION MANAGEMENT; CLINICAL-OUTCOMES; I TRIAL; RADIOTHERAPY; METASTASES; SBRT;
D O I
10.3390/curroncol30100667
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The utilization of stereotactic body radiation therapy for the treatment of liver metastasis has been widely studied and has demonstrated favorable local control outcomes. However, several predictive factors play a crucial role in the efficacy of stereotactic body radiation therapy, such as the number and size (volume) of metastatic liver lesions, the primary tumor site (histology), molecular biomarkers (e.g., KRAS and TP53 mutation), the use of systemic therapy prior to SBRT, the radiation dose, and the use of advanced technology and organ motion management during SBRT. These prognostic factors need to be considered when clinical trials are designed to evaluate the efficacy of SBRT for liver metastases.
引用
收藏
页码:9230 / 9243
页数:14
相关论文
共 50 条
  • [1] Stereotactic body radiation therapy and oligometastases
    Bourgier, C.
    Azria, D.
    Fenoglietto, P.
    Riou, O.
    Almaghrabi, M. -Y.
    Supiot, S.
    Mornex, F.
    Giraud, P.
    CANCER RADIOTHERAPIE, 2014, 18 (04): : 337 - 341
  • [2] Stereotactic Body Radiation Therapy for Oligometastases
    Lo, Simon S.
    Teh, Bin S.
    Mayr, Nina A.
    Olencki, Thomas E.
    Wang, Jian Z.
    Grecula, John C.
    Lu, Jiade J.
    Timmerman, Robert D.
    DISCOVERY MEDICINE, 2010, 10 (52) : 247 - 254
  • [3] Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases
    Alongi, Filippo
    Arcangeli, Stefano
    Filippi, Andrea Riccardo
    Ricardi, Umberto
    Scorsetti, Marta
    ONCOLOGIST, 2012, 17 (08) : 1100 - 1107
  • [4] Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review
    Almaghrabi, Mohammed Yahia
    Supiot, Stephane
    Paris, Francois
    Mahe, Marc-Andre
    Rio, Emmanuel
    RADIATION ONCOLOGY, 2012, 7
  • [5] Stereotactic body radiation therapy for oligometastases
    Lo, Simon S.
    Fakiris, Achilles J.
    Teh, Bin S.
    Cardenes, Higinia R.
    Henderson, Mark A.
    Forquer, Jeffrey A.
    Papiez, Lech
    McGarry, Ronald C.
    Wang, Jian Z.
    Li, Kaile
    Mayr, Nina A.
    Timmerman, Robert D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (05) : 621 - 635
  • [6] Local Control Following Stereotactic Body Radiation Therapy for Liver Tumors
    Klement, Rainer J.
    Andratschke, Nicolaus
    Guckenberger, Matthias
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (01): : 249 - 250
  • [7] Overall and chemotherapy-free survival following stereotactic body radiation therapy for abdominopelvic oligometastases
    Shahi, Jeevin
    Peng, Jonathan
    Donovan, Elysia
    Vansantvoort, Jasmin
    Wong, Raimond
    Tsakiridis, Theodoros
    Quan, Kimmen
    Parpia, Sameer
    Swaminath, Anand
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (04) : 563 - 569
  • [8] Local Control After Stereotactic Body Radiation for Liver Tumors
    Ohri, Pelvis Nitin
    Tome, Wolfgang A.
    Romero, Alejandra Mendez
    Miften, Moyed
    Ten Haken, Randall K.
    Dawson, Laura A.
    Grimm, Jimm
    Yorke, Ellen
    Jackson, Andrew
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (01): : 188 - 195
  • [9] Stereotactic radiation therapy for liver metastases: factors affecting local control and survival
    Andratschke, Nicolaus H. J.
    Nieder, Carsten
    Heppt, Franz
    Molls, Michael
    Zimmermann, Frank
    RADIATION ONCOLOGY, 2015, 10
  • [10] Stereotactic body radiation therapy for bone oligometastases
    Naessens, C.
    Chamois, J.
    Supiot, S.
    Faivre, J. -c.
    Arnaud, A.
    Thureau, S.
    CANCER RADIOTHERAPIE, 2024, 28 (01): : 111 - 118